Packaged snacks company Mondelez (NASDAQ:MDLZ) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 3.1% year on year to $9.60 billion. Its non-GAAP profit of $0.65 per share was in line with analysts’ consensus estimates.
H&R Block (NYSE:HRB) Beats Q4 Sales Targets But Stock Drops
Tax preparation company H&R Block (NYSE:HRB) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales were flat year on year at $179.1 million. The company expects the full year’s revenue to be around $3.72 billion, close to analysts’ estimates. Its non-GAAP loss of $1.73 per share was 8.6% below analysts’ consensus estimates.
Stock market today: Dow, S&P 500, Nasdaq recover as traders assess tariff developments, new jobs data
Investors are assessing China's instant retaliation to Trump's additional tariffs, amid worries about the risk of a trade war.
Snap’s (NYSE:SNAP) Q4 Sales Beat Estimates, Stock Jumps 10.4%
Social network Snapchat (NYSE: SNAP) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 14.4% year on year to $1.56 billion. Its non-GAAP profit of $0.16 per share was 13.6% above analysts’ consensus estimates.
S&P 500 Gains and Losses Today: Palantir Stock Pops as Results Show AI Strength
The S&P 500 added 0.7% on Tuesday, Feb. 4, as investors evaluated developments on U.S. tariffs, labor market data, and the latest earnings news.
AMD (NASDAQ:AMD) Exceeds Q4 Expectations, Quarterly Revenue Guidance Slightly Exceeds Expectations
Computer processor maker AMD (NASDAQ:AMD) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 24.2% year on year to $7.66 billion. Guidance for next quarter’s revenue was better than expected at $7.1 billion at the midpoint, 1.3% above analysts’ estimates. Its non-GAAP profit of $1.09 per share was in line with analysts’ consensus estimates.
Varonis (NASDAQ:VRNS) Misses Q4 Revenue Estimates
Data protection and security software company Varonis (NASDAQ:VRNS) fell short of the market’s revenue expectations in Q4 CY2024 as sales rose 2.9% year on year to $158.5 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $132.5 million at the midpoint, or 1.7% above analysts’ estimates. Its non-GAAP profit of $0.18 per share was 27.3% above analysts’ consensus estimates.
Amgen’s (NASDAQ:AMGN) Q4 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations
Biotech company Amgen (NASDAQ:AMGN) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 10.9% year on year to $9.09 billion. The company’s full-year revenue guidance of $35 billion at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $5.31 per share was 4.6% above analysts’ consensus estimates.
'Blockchain Gandalf’ on crypto, the metaverse and saving the world
Keir Finlow-Bates is not your typical blockchain expert. Known online as "Blockchain Gandalf," his LinkedIn tagline reads, "I walk through the woods thinking about blockchain." That alone tells you he brings a different perspective to the space.
SEC Commissioner Hester Peirce Lays Out 10 Priorities for New Crypto Task Force
Peirce also urged crypto companies to be patient as the agency decides how to “disentangle” itself from litigation initiated under former Chair Gary Gensler.